Edaravone dexborneol for acute ischaemic stroke among patients undergoing endovascular treatment: a systematic review and meta-analysis.
BACKGROUND Acute ischaemic stroke (AIS) remains a major cause of disability and mortality worldwide. Endovascular treatment (EVT) is the standard of care for large vessel occlusion, yet a favourable neurological outcome is not achieved in all patients. Edaravone dexborneol (ED) has been proposed as an adjuvant therapy...